Recent Quotes
You have no recent quotes
There is no Press for this Ticker
Sector: Health Care.Industry: Biotechnology
Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. Its molecule, AMP945 is a pure play inhibitor, while the second molecule, AMP886, is a multi-action molecule that hits two other important cancer pathways - VEGFR3 and FLT3.
Related Companies
| Ticker | Company | Price | Change | Chg % | Mkt Cap | |
|---|---|---|---|---|---|---|
| INNMF | Amplia Therapeutics | 0.19 | 0.00 | 0% | 20.6M |
Amplia Therapeutics Company Questions & Answers
Q
How do I buy Amplia Therapeutics (INNMF) stock?
A
You can purchase shares of Amplia Therapeutics (OTC: INNMF) through any online brokerage.
Q
Who are Amplia Therapeutics's (INNMF) main competitors?
A
There are no as such competitors for Amplia Therapeutics.
Q
What is the target price for Amplia Therapeutics?
A
There is no analysis for Amplia Therapeutics
Q
How much is Amplia Therapeutics (INNMF) stock ?
A
The stock price for Amplia Therapeutics (OTC: INNMF) is $0.191 last updated Thu Apr 15 2021 15:49:20 GMT+0000 (Coordinated Universal Time).
Q
When is the next Amplia Therapeutics (INNMF) dividend?
A
There are no upcoming dividends for Amplia Therapeutics.
Q
When is Amplia Therapeutics (OTC:INNMF) reporting earnings?
A
There are no earnings for Amplia Therapeutics
Q
When is the upcoming split for INNMF?
A
There is no upcoming split for Amplia Therapeutics.